Rockland Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.6M | Sell |
16,303
-2,172
| -12% | -$2.22M | 0.77% | 39 |
|
|
2026
Q1 | $17M | Sell |
18,475
-547
| -3% | -$555K | 0.68% | 44 |
|
|
2025
Q4 | $20.4M | Sell |
19,022
-494
| -3% | -$472K | 0.81% | 40 |
|
|
2025
Q3 | $14.9M | Buy |
19,516
+5,517
| +39% | +$4.11M | 0.61% | 50 |
|
|
2025
Q2 | $10.9M | Buy |
13,999
+239
| +2% | +$186K | 0.53% | 57 |
|
|
2025
Q1 | $11.4M | Buy |
13,760
+2,089
| +18% | +$1.74M | 0.57% | 56 |
|
|
2024
Q4 | $9.01M | Buy |
11,671
+253
| +2% | +$209K | 0.46% | 64 |
|
|
2024
Q3 | $10.1M | Sell |
11,418
-173
| -1% | -$156K | 0.5% | 62 |
|
|
2024
Q2 | $10.5M | Buy |
11,591
+9,011
| +349% | +$7.21M | 0.55% | 53 |
|
|
2024
Q1 | $2.01M | Sell |
2,580
-338
| -12% | -$241K | 0.11% | 96 |
|
|
2023
Q4 | $1.7M | Sell |
2,918
-16,231
| -85% | -$9.47M | 0.09% | 108 |
|
|
2023
Q3 | $10.3M | Sell |
19,149
-317
| -2% | -$163K | 0.62% | 49 |
|
|
2023
Q2 | $9.13M | Sell |
19,466
-7,204
| -27% | -$3.02M | 0.55% | 59 |
|
|
2023
Q1 | $9.16M | Sell |
26,670
-155
| -0.6% | -$52.3K | 0.58% | 58 |
|
|
2022
Q4 | $9.81M | Sell |
26,825
-1,740
| -6% | -$617K | 0.62% | 55 |
|
|
2022
Q3 | $9.24M | Sell |
28,565
-1,883
| -6% | -$597K | 0.66% | 51 |
|
|
2022
Q2 | $9.87M | Sell |
30,448
-3,981
| -12% | -$1.19M | 0.68% | 51 |
|
|
2022
Q1 | $9.86M | Sell |
34,429
-10,255
| -23% | -$2.64M | 0.63% | 51 |
|
|
2021
Q4 | $12.3M | Sell |
44,684
-927
| -2% | -$235K | 0.79% | 42 |
|
|
2021
Q3 | $10.5M | Buy |
45,611
+1,437
| +3% | +$355K | 0.74% | 45 |
|
|
2021
Q2 | $10.1M | Sell |
44,174
-192
| -0.4% | -$38.6K | 0.7% | 51 |
|
|
2021
Q1 | $8.29M | Buy |
44,366
+3,602
| +9% | +$705K | 0.6% | 58 |
|
|
2020
Q4 | $6.88M | Sell |
40,764
-72
| -0.2% | -$10.8K | 0.53% | 57 |
|
|
2020
Q3 | $6.04M | Buy |
40,836
+8
| +0% | +$1.24K | 0.52% | 57 |
|
|
2020
Q2 | $6.7M | Sell |
40,828
-2,263
| -5% | -$347K | 0.6% | 55 |
|
|
2020
Q1 | $5.98M | Sell |
43,091
-3,241
| -7% | -$445K | 0.61% | 54 |
|
|
2019
Q4 | $6.09M | Buy |
46,332
+1,120
| +2% | +$130K | 0.5% | 62 |
|
|
2019
Q3 | $4.85M | Buy |
45,212
+1,307
| +3% | +$146K | 0.44% | 66 |
|
|
2019
Q2 | $4.86M | Buy |
43,905
+604
| +1% | +$71.1K | 0.48% | 63 |
|
|
2019
Q1 | $5.62M | Buy |
43,301
+6,259
| +17% | +$761K | 0.6% | 59 |
|
|
2018
Q4 | $4.29M | Sell |
37,042
-1,840
| -5% | -$206K | 0.53% | 62 |
|
|
2018
Q3 | $4.17M | Sell |
38,882
-4,695
| -11% | -$469K | 0.51% | 59 |
|
|
2018
Q2 | $3.72M | Sell |
43,577
-1,147
| -3% | -$94.2K | 0.48% | 62 |
|
|
2018
Q1 | $3.46M | Buy |
44,724
+2,320
| +5% | +$187K | 0.46% | 60 |
|
|
2017
Q4 | $3.58M | Buy |
42,404
+660
| +2% | +$56.2K | 0.46% | 60 |
|
|
2017
Q3 | $3.57M | Buy |
41,744
+1,810
| +5% | +$148K | 0.53% | 55 |
|
|
2017
Q2 | $3.29M | Buy |
39,934
+8,070
| +25% | +$658K | 0.51% | 55 |
|
|
2017
Q1 | $2.68M | Sell |
31,864
-2,205
| -6% | -$177K | 0.42% | 60 |
|
|
2016
Q4 | $2.51M | Buy |
34,069
+2,264
| +7% | +$169K | 0.4% | 62 |
|
|
2016
Q3 | $2.55M | Buy |
31,805
+90
| +0.3% | +$7.2K | 0.44% | 59 |
|
|
2016
Q2 | $2.5M | Buy |
31,715
+1,715
| +6% | +$129K | 0.43% | 57 |
|
|
2016
Q1 | $2.16M | Buy |
30,000
+330
| +1% | +$25K | 0.39% | 59 |
|
|
2015
Q4 | $2.5M | Sell |
29,670
-430
| -1% | -$35.7K | 0.44% | 56 |
|
|
2015
Q3 | $2.52M | Buy |
30,100
+825
| +3% | +$69.6K | 0.49% | 49 |
|
|
2015
Q2 | $2.44M | Sell |
29,275
-335
| -1% | -$25.5K | 0.49% | 46 |
|
|
2015
Q1 | $2.15M | Buy |
29,610
+1,360
| +5% | +$96.8K | 0.45% | 49 |
|
|
2014
Q4 | $1.95M | Buy |
28,250
+501
| +2% | +$33.8K | 0.4% | 56 |
|
|
2014
Q3 | $1.8M | Buy |
27,749
+4,350
| +19% | +$275K | 0.4% | 51 |
|
|
2014
Q2 | $1.46M | Buy |
+23,399
| New | +$1.4M | 0.33% | 51 |
|
Other funds holding LLY
Rockland Trust's LLY Position: Q2 2026 in Review
Rockland Trust reduced its Eli Lilly (LLY) stake by 12% in Q2 2026, selling an estimated $2.22M and leaving 16,303 shares worth $19.6M. The position accounts for 0.77% of the portfolio, ranked #39.
Rockland Trust first reported a position in LLY in Q2 2014 and has held it in 49 quarters since. The position peaked at $20.4M in Q4 2025. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Rockland Trust held 16,303 shares of Eli Lilly worth $19.6M as of Q2 2026.
- Rockland Trust sold 2,172 Eli Lilly shares in Q2 2026, an estimated $2.22M.
- Eli Lilly made up 0.77% of Rockland Trust's portfolio in Q2 2026, its #39 holding.
- Rockland Trust first reported a position in Eli Lilly in Q2 2014 and has held it in 49 quarters since.
- Rockland Trust's Eli Lilly position peaked at $20.4M in Q4 2025.
- 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.